5. patologi arf crf tp

30
 Pathogenesis and Management of Renal Failure and Replacement Therapy for Stage V Chronic Renal Disease dr. Heru Prasanto, Bambang Djarwoto Sub bagian Ginjal Hipertensi, Bag Penyakit Dalam FK UGM / RSUP DR Sardjito, Yo gyakarta

Upload: byzantine-wulandari-parubak

Post on 30-Oct-2015

12 views

Category:

Documents


0 download

DESCRIPTION

hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh

TRANSCRIPT

Page 1: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 1/30

  Pathogenesis and Management of 

Renal Failure

and

Replacement Therapy forStage V Chronic Renal Disease

dr. Heru Prasanto, Bambang DjarwotoSub bagian Ginjal Hipertensi,

Bag Penyakit Dalam FK UGM / RSUP DR Sardjito, Yogyakarta

Page 2: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 2/30

Page 3: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 3/30

ACUTE RENAL FAILURE 

• ACUTE renal failure is characterized by a

deterioration of renal function over a period

of hours to days, resulting in the failure of the

kidney to excrete nitrogenous waste products

and to maintain fluid and electrolyte

homeostasis.

Page 4: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 4/30

The RIFLE classification of ARF is as follows:

• Risk (R) - Increase in serum creatinine level X 1.5 or

decrease in GFR by 25%, or UO <0.5 mL/kg/h for 6hours• Injury (I) - Increase in serum creatinine level X 2.0 or

decrease in GFR by 50%, or UO <0.5 mL/kg/h for 12hours

• Failure (F) - Increase in serum creatinine level X 3.0,decrease in GFR by 75%, or serum creatinine level > 4mg/dL; UO <0.3 mL/kg/h for 24 hours, or anuria for12 hours

• Loss (L) - Persistent ARF, complete loss of kidney

function >4 wk• End-stage kidney disease (E) - Loss of kidney function

>3 months

Page 5: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 5/30

Prerenal

• Prerenal azotemia is rapidly reversible if the underlying

cause is corrected.

• In the outpatient setting, vomiting, diarrhea, poor .uid

intake, fever, use of diuretics, and heart failure are allcommon causes.

• Elderly patients are particularly susceptible to prerenal

azotemia because of their predisposition to hypovolemia

and high prevalence of renal-artery atheroscleroticdisease.

• Among hospitalized patients, prerenal azotemia is often

due to cardiac failure, liver dysfunction,or septic shock.

Page 6: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 6/30

Etiology pre renal ARF,

hypovolemia, hypotension and hypoperfusionkidney:

 – Severe blood loss: trauma, bleeding. – Loss of plasma : combustio, peritonitis.

 – Loss of water and electrolyte : acutegastroenteritis

 – Hypoalbuminemia

 – Heart failure: myocard infarct.

 – Neonatus septic shock or severe asphyxia

Page 7: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 7/30

Post renal Causes 

• Acute renal failure occurs when both urinary outfow

tracts are obstructed or when one tract is obstructed

in a patient with a single functional kidney.

• Obstruction is most commonly due to prostatichypertrophy, cancer of the prostate or cervix, or

retroperitoneal disorders and often presents in the

outpatient setting.

• A neurogenic bladder can result in functional

obstruction.

• Other, less frequent, postrenal causes of acute failure

can be intraluminal, such as bilateral renal calculi

Page 8: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 8/30

ARF Post renal

Obstruction cause by:

 – Congenital : valvula uretrovesical

 – Urolithiasis

 – Trombosis arteri/vena renalis

 – Tumor (prostate, pelvis)

Page 9: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 9/30

Intrinsic Causes 

• Intrinsic renal diseases that result in acute renalfailure are categorized according to the primary siteof injury: tubules, interstitium, vessels, orglomerulus.

• Injury to the tubules is most often ischemic or toxicin origin.

• ischemic tubular necrosis represent when bloodflow is suffciently the death of tubular cells.

• most cases are reversible if the underlying cause iscorrected (Aminoglycoside antibiotics andradiocontrast agents, chemotherapeutic agents /cisplatin)

• irreversible cortical necrosis can occur if the ischemiais severe, especially if the disease process includesmicrovascular coagulation such as may occur withobstetrical complications, snake bites

Page 10: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 10/30

intrinsic

damage of tubule epithellial: acute tubular

necrosis (ATN)

• Iskemic type: prolong ARF

• Nephrotoxic type: trombosis, hipertensi

damage of glomerulus

• Acute Glomerulonefritis

• Hemolitic uremic syndrome

Vascular disease: hypertension, thrombosis

Page 11: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 11/30

Page 12: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 12/30

Conditions That Lead to Ischemic Acute Renal Failure.

Page 13: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 13/30

ARF Therapy

• There is no consensus among nephrologists as

to when to begin dialysis or how frequently to

perform dialysis.

• Although studies that evaluated early and

intensive dialysis suggested that such an

approach improved survival and led to a more

rapid recovery

Page 14: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 14/30

Chronic kidney disease (CKD)

• is a progressive loss of renal function over a

period of months or years

• Five stages Each stage is a progression

through an abnormally low and deteriorating

glomerular filtration rate, which is usually

determined indirectly by the creatinine level

in blood serum

Page 15: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 15/30

Signs and symptoms

• can be detected as an increase in serum creatinine or protein

in the urine.

As the kidney function decreases:

• Blood pressure is increased due to fluid overload and production of 

vasoactive hormones leading to hypertension and congestive heart failure • Urea accumulates, azotemia / uremia 

(symptoms ranging from lethargy to pericarditis and encephalopathy)

• Potassium accumulates in the blood hyperkalemia 

Erythropoietin synthesis is decreased anemia • Fluid volume overload  pulmonary edema 

• Metabolic acidosis, decreased bicarbonate by thekidney

Page 16: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 16/30

Stage 1 CKD• Slightly diminished function; Kidney damage with

normal or increased GFR (>90 mL/min/1.73 m2).•

Kidney damage is defined as pathologicabnormalities or markers of damage, includingabnormalities in blood or urine test or imagingstudies

Stage 2 CKD• Mild reduction in GFR (60-89 mL/min/1.73 m2) with

kidney damage.Stage 3 CKD• Moderate reduction in GFR (30-59 mL/min/1.73 m2) Stage 4 CKD•

Severe reduction in GFR (15-29 mL/min/1.73 m2) Stage 5 CKD• Established kidney failure (GFR <15 mL/min/1.73 m2,• or permanent renal replacement therapy (RRT)

Page 17: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 17/30

Stages of Chronic Kidney Disease: A Clinical Action Plan

Stage Description GFR

(mL/min/1.73m3)

Action

1 Kidney damage with

normal or  GFR

90 Diagnosis & Treatment, Treat

comorbid condition, slowing

progression, CVD riskreduction

2 Kidney damage with mild  

GFR

60  – 89 Estimating Progression

3 Moderate GFR 30  – 59 Evaluating & Treating

complications

4 Severe GFR 15  – 29 Preparation for kidney

replacement therapy

5 Kidney failure < 15 or dialiysis Replacement (if uremia

present)

Page 18: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 18/30

Treatment

The goal of therapy is to slow down or halt theotherwise relentless progression of CKD to

stage 5.

• Control of blood pressure and treatment of 

the original disease, whenever feasible, are

the broad principles of management.

• Generally, angiotensin converting enzyme

inhibitors (ACEIs) or angiotensin II receptor

antagonists (ARBs) are used, as they have

been found to slow the progression of CKD to

stage 5.

Page 19: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 19/30

Renal Replacement Therapy

• When renal failure is severe, and about 90% of renal function is lost, a patient requires a formof renal replacement therapy to survive

a renal transplant or dialysis.

A renal transplant is the surgical placement of a kidney from a kidney donor into a patientwith kidney failure.

Page 20: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 20/30

High-risk factor in transplantation

• Age

• Unfavorable psychological profile

• Unfavorable medical status – Pulmonary factors (smoking)

 – Recurrent primary renal disease

 – Diabetes

 – Cardiovascular factors (unstable angina)

 – Severe hypertension

 – Neoplasia – Chronic infection(s)

 – Obesity

Page 21: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 21/30

• Dialysis hemodilysis

peritoneal dialysis

• is a process that cleans and filters the blood,removing harmful wastes and excess salt and fluidsby passing blood across a semipermeablemembrane.

• Wastes from the blood diffuse across the membraneinto a cleansing solution (dialysate) and bicarbonatediffuses into the blood to neutralize excess acid.

• Dialysis can control blood pressure and help maintaina balance of electrolytes, including potassium,sodium, and chloride.

Page 22: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 22/30

 Arah aliran darah

 Arah aliran dialisat

Inlet darah

(merah) Outlet darah

(biru) 

Inlet cairan dialisat Outlet cairan dialisat 

Gambar skematis dializer  

Page 23: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 23/30

Anatomy of a Hemofilter

23

blood in

blood out

dialysate

in

dialysate

out

Outside the Fiber (effluent) Inside the Fiber (blood)

Cross Sectionhollow fiber membrane

Page 24: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 24/30

Hemodialysis

• can be performed at a dialysis center

• hemodialysis treatment is provided by trainednurses and technicians.

• Hemodialysis is usually performed 3 timesweekly, with each treatment lasting 2 to 4hours.

• Patients can read, write, sleep, talk, or watchtelevision during treatment.

Page 25: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 25/30

Page 26: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 26/30

Page 27: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 27/30

Page 28: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 28/30

Page 29: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 29/30

Peritoneal dialysis

• uses the peritoneal membrane, the lining of the

abdomen, to remove excess water, wastes, and

chemicals from the body.

• A dialysate passes through the abdomen via a

surgically placed catheter.• Fluid, wastes, and chemicals pass from capillaries in

the peritoneal membrane into the dialysate.

• No machine is necessary.

• After 4 to 6 hours, the solution is drained back into

the bag and replaced with fresh solution. The

solution is usually changed 4 times a day.

Page 30: 5. Patologi Arf Crf Tp

7/16/2019 5. Patologi Arf Crf Tp

http://slidepdf.com/reader/full/5-patologi-arf-crf-tp 30/30